10Oct 2023
Non-Cardiac Comorbidities and Aggressive Oral Treatment Up-Titration in Heart Failure Patients Following Recent Hospitalization

Non-Cardiac Comorbidities and Aggressive Oral Treatment Up-Titration in Heart Failure Patients Following Recent Hospitalization

The STRONG-HF trial investigated the impact of non-cardiac comorbidities (NCCs) on the efficacy and safety of high-intensity care (HIC) versus usual care (UC) for stable patients with elevated natriuretic peptides. Eight NCCs, including diabetes and chronic obstructive pulmonary disease, were assessed. Among 1078 patients, varying NCC numbers were observed. HIC demonstrated consistent achievement of complete heart failure (HF) therapies, with no significant difference in 180-day death or HF rehospitalization rates when compared to UC across NCC groups. NCCs did not affect quality of life or incidence of adverse events. The findings suggest that HIC benefits HF patients, even with multiple NCCs.

  • #cardiology

Like

Save

Share